Note 17 - Segments - Summarized Financial Information of Reportable Segments (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2022 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|||||||
Revenue | $ 159,806 | $ 166,100 | $ 187,561 | $ 102,601 | $ 152,945 | $ 127,636 | $ 157,530 | $ 103,342 | $ 616,068 | $ 541,453 | $ 480,154 | ||||||
Adjusted EBITDA | 86,780 | 79,536 | 74,892 | ||||||||||||||
Depreciation and amortization expense | 20,938 | 20,316 | 19,737 | ||||||||||||||
Assets | 596,891 | 572,476 | 596,891 | 572,476 | 579,202 | ||||||||||||
Capital Expenditures | 12,402 | 11,881 | 14,682 | ||||||||||||||
Interest expense - net | (11,253) | (11,839) | (20,238) | ||||||||||||||
Depreciation expense | 10,418 | 9,634 | 8,806 | ||||||||||||||
Amortization | 10,520 | 10,682 | 10,931 | ||||||||||||||
Purchase accounting (1) | [1] | 0 | 0 | (2,017) | |||||||||||||
Stock based compensation | 6,730 | 5,794 | 2,830 | ||||||||||||||
Impairment charges | 0 | 1,211 | 127,872 | ||||||||||||||
Debt modification expense | 0 | 0 | 3,542 | ||||||||||||||
Loss on extinguishment of debt | 0 | 4,936 | 0 | ||||||||||||||
COVID-19 (2) | [2] | 48 | 82 | 1,391 | |||||||||||||
Other charges (3) | [3] | 450 | 770 | 128 | |||||||||||||
Income (Loss) before taxes | 13,021 | $ 16,175 | $ 23,090 | $ (4,925) | 10,770 | $ 8,234 | $ 14,919 | $ 665 | 47,361 | 34,588 | (98,829) | ||||||
Work Truck Attachments [Member] | |||||||||||||||||
Revenue | 382,296 | 325,707 | 252,838 | ||||||||||||||
Adjusted EBITDA | 78,211 | 77,369 | 62,532 | ||||||||||||||
Depreciation and amortization expense | 12,901 | 11,937 | 10,824 | ||||||||||||||
Assets | 397,557 | 384,566 | 397,557 | 384,566 | 365,210 | ||||||||||||
Capital Expenditures | 9,526 | 10,434 | 13,174 | ||||||||||||||
Work Truck Solutions [Member] | |||||||||||||||||
Revenue | 233,772 | 215,746 | 227,316 | ||||||||||||||
Adjusted EBITDA | 8,569 | 2,167 | 12,360 | ||||||||||||||
Depreciation and amortization expense | 8,037 | 8,379 | 8,913 | ||||||||||||||
Assets | $ 199,334 | $ 187,910 | 199,334 | 187,910 | 213,992 | ||||||||||||
Capital Expenditures | $ 2,876 | $ 1,447 | $ 1,508 | ||||||||||||||
|
X | ||||||||||
- Definition The amount of Adjusted EBITDA. No definition available.
|
X | ||||||||||
- Definition The amount of covid-19 expenses. No definition available.
|
X | ||||||||||
- Definition Represents other charges. No definition available.
|
X | ||||||||||
- Definition The amount of purchase accounting- (reversal of) earn out compensation expense during the period. No definition available.
|
X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of amortization of deferred charges applied against earnings during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The net amount of nonoperating interest income (expense). No definition available.
|
X | ||||||||||
- Definition The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|